Model-based AI to de-risk and accelerate the development of
• DTx ,
• digital biomarkers , and
• digital clinical measures
to be integrated with classical medications making drugs smart.
Bringing preclinical rigor to digital health—fast, explainable, and designed for differentiation and IP protection.
Product Owner-level support to organizations that recognize this as a Horizon 2 activity.
Harness virtual patients and in silico simulation to design faster, smarter clinical trials for d...
Enhancing Drug Lifecycle Management and Post-Market Optimization.